Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Emma Kampouraki.
Newcastle Authors
Title
Year
Full text
Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
Professor Farhad Kamali
et al.
Assessment of exposure to direct oral anticoagulants in elderly hospitalised patients
2021
Dr Emma Kampouraki
Dr Salah Abohelaika
Dr Peter Avery
Dr Tina Biss
Dr Hilary Wynne
et al.
Elderly people are inherently sensitive to the pharmacological activity of rivaroxaban: implications for DOAC prescribing
2021
Dr Alison Bray
Dr Emma Kampouraki
Amanda Winter
Dr Peter Messer
Dr Sara Graziadio
et al.
High variability in sepsis guidelines in UK: Why does it matter?
2020
Dr Paul Ayuk
Dr Emma Kampouraki
Frances Sidgwick
Professor Farhad Kamali
Investigation of dabigatran secretion into breast milk: Implications for oral thromboprophylaxis in post-partum women
2019
Dr Emma Kampouraki
Professor Farhad Kamali
Pharmacogenetics of anticoagulants used for stroke prevention in patients with atrial fibrillation
2019
Dr Salah Abohelaika
Dr Hilary Wynne
Dr Peter Avery
Dr Emma Kampouraki
Professor Farhad Kamali
et al.
Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery
2018
Dr Emma Kampouraki
Dr Peter Avery
Dr Hilary Wynne
Dr Tina Biss
Dr John Hanley
et al.
Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: A randomised clinical trial
2017
Dr Emma Kampouraki
Dr Peter Avery
Dr Tina Biss
Professor Farhad Kamali
Association between
CYP4F2
genotype and circulating plasma vitamin K concentration in children on chronic warfarin therapy: Possible long-term implications for bone development and vascular health
2017
Dr Emma Kampouraki
Professor Farhad Kamali
Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease
2017